Shi Wu

Shi Wu

Auto-generated profile, based on publicly available information

Shi Wu

School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, 437100 Xianning, Hubei, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2010 in Journal of Polymer Science Part A: Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
SWShi Wu
Shi Wu
NYNianfa Yang
Nianfa Yang
YLYanling Liu
Yanling Liu
JCJing Cao
Jing Cao
HHHai Hu
Hai Hu
JLJi Liu
Ji Liu

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YLYuning Liu
Yuning Liu
SWShi Wu
Shi Wu
QZQian Zhao
Qian Zhao
ZYZhen Yang
Zhen Yang
XYXiaojun Yan
Xiaojun Yan
WYWei Yu
Wei Yu
Ample clinical case reports suggest a high incidence of cardiomyopathy in diabetes mellitus (DM). Recent evidence supports an essential role of trehalose (TLS) in cardiomyocyte survival signaling. Our previous study found that prokineticin2 (PK2) was involved in the process of diabetic cardiomyopathy (DCM). The present study examined the protective effects and mechanisms of TLS on DM‐induced cardiomyocyte injury in mice and H9c2 cardiomyocytes. C57BL/6J mice were intraperitoneally injected with 50 mg·kg-1·d-1 streptozotocin for five consecutive days to establish an experimental diabetic model and then administered TLS (1 mg·g-1·d-1, i.p.) for two days every 4 weeks and given 2% TLS in drinking water for 24 weeks. Echocardiography, myocardial structure, apoptosis, pyroptosis, autophagy, and the PK2/PKR pathway were assessed. Cardiomyocytes exposed to high glucose (HG) were treated with TLS in the absence or presence of the PK2 antagonist PKRA7, and proteins involved in apoptosis, autophagy, and pyroptosis and the PK2/PKR pathways were evaluated using Western blot analysis. Diabetic mice demonstrated metabolic disorder, abnormal myocardial zymograms, and aberrant myocardial systolic and diastolic function, which were accompanied by pronounced apoptosis, pyroptosis, and dampened autophagy. TLS treatment relieved these effects. PK2 and receptor expressions were downregulated in diabetic mice, and TLS nullified this effect. PKRA7 eliminated the impact of TLS on cardiomyocytes. This evidence suggests that TLS rescues DM‐induced myocardial function, pyroptosis, and apoptosis, likely via the PK2/PKR pathway.

1 May 2026 in Giant
Verified
Journal Article
Open access
LGLiyuan Guo
Liyuan Guo
CLChunyan Liu
Chunyan Liu
RLRong Li
Rong Li
YWYifan Wu
Yifan Wu
GKGong Kuang
Gong Kuang
SWShi Wu
Shi Wu

13 August 2026 in Die Pharmazie
Verified
Journal Article
Open access
PDF file
LGLiyuan Guo
Liyuan Guo
MDMan Di
Man Di
ZDZhiyan Dong
Zhiyan Dong
DZDa Zhang
Da Zhang
XZXiaoqing Zhu
Xiaoqing Zhu
CLChao Liu
Chao Liu
Background:Diabetes mellitus is a major global health concern. DPP-4 (dipeptidyl peptidase-4) inhibitors containing a 2-cyanopyrrolidine scaffold are in clinical use; however, systematic evaluation of amides derived from amino acids adjacent to the N-2 position of GLP-1 (glucagon-like peptide-1) has not been reported.Methods:A total of eight 2-cyanopyrrolidine derivatives, grouped into three series, were synthesized from N-Boc-protected amino acids via condensation with 2-cyanopyrrolidine followed by deprotection. The compounds were characterized by nuclear magnetic resonance (NMR), elemental analysis, and mass spectrometry (MS). DPP-4 inhibitory activity was evaluated in vitro using a DPP-IV Glo™ assay, with sitagliptin as a control. IC50 (Half Maximal Inhibitory Concentration) values were determined from three independent replicates (n = 3) and calculated by nonlinear regression. Results:Compounds 4d, 4g, and 4h exhibited excellent DPP-4 inhibition, with IC50 values of 1.36 ± 0.09, 5.24 ± 0.31, and 4.83 ± 0.22 nM, respectively. Compound 4d (histidine) was more potent than sitagliptin (6.13 ± 0.42 nM). The bis-cyanopyrrolidine derivatives 4g and 4h also showed strong activity. The remaining compounds (4a–4c, 4e, 4f) displayed moderate inhibition (IC50 112–181 nM).Conclusions:Aminoacyl-2-cyanopyrrolidine derivatives bearing an imidazole or bis-cyanopyrrolidine structure are potent DPP-4 inhibitors. These findings highlight the importance of neighboring GLP-1 amino acid residues (positions 1 and 3) in inhibitor design. Further cellular and in vivo studies are warranted to evaluate the therapeutic potential of these compounds.